Leucovorin /00566701/


Indications and Reactions:

Role Indications Reactions
Secondary
Colorectal Cancer Metastatic 24.2%
Metastases To Liver 10.9%
Colon Cancer 9.7%
Colorectal Cancer 8.9%
Metastases To Lung 7.3%
Rectal Cancer 7.3%
Oesophageal Adenocarcinoma 4.4%
Burkitt's Lymphoma 4.0%
Non-hodgkin's Lymphoma 4.0%
Adenocarcinoma Of Colon 3.6%
Metastases To Lymph Nodes 3.6%
Gastric Cancer 2.8%
Rheumatoid Arthritis 2.0%
Neoplasm Malignant 1.6%
Product Used For Unknown Indication 1.6%
Colorectal Cancer Stage Iii 1.2%
Hypertension 1.2%
Dehydration 0.8%
Abdominal Pain 0.4%
Diarrhoea 0.4%
Thrombocytopenia 10.5%
Foetal Growth Restriction 7.9%
Paraesthesia 7.9%
Pyrexia 7.9%
Renal Disorder 7.9%
Stress Cardiomyopathy 7.9%
Anaemia 5.3%
Febrile Neutropenia 5.3%
Neutropenia 5.3%
Oliguria 5.3%
Respiratory Failure 5.3%
Asthenia 2.6%
Death 2.6%
Dehydration 2.6%
Diarrhoea 2.6%
Gastrointestinal Perforation 2.6%
Haemoglobin Decreased 2.6%
Interstitial Lung Disease 2.6%
Neutropenic Sepsis 2.6%
Orthostatic Hypotension 2.6%
Concomitant
Product Used For Unknown Indication 29.1%
Colorectal Cancer Metastatic 15.1%
Rectal Cancer 9.9%
Colon Cancer 8.3%
Rheumatoid Arthritis 5.5%
B-cell Lymphoma 5.0%
Metastases To Liver 4.4%
Mantle Cell Lymphoma 4.1%
Chemotherapy 2.3%
Prophylaxis 2.3%
Hypertension 2.1%
Osteosarcoma 1.8%
Psoriatic Arthropathy 1.8%
Constipation 1.4%
Metastases To Lung 1.4%
Colon Cancer Stage Iv 1.1%
Depression 1.1%
Oesophageal Carcinoma 1.1%
Premedication 1.1%
Insomnia 0.9%
Injection Site Pain 11.5%
Therapeutic Response Decreased 7.7%
Drug Ineffective 5.8%
Hypomagnesaemia 5.8%
Skin Ulcer 5.8%
Stress Fracture 5.8%
Weight Decreased 5.8%
Xerosis 5.8%
Gamma-glutamyltransferase Increased 3.8%
Injection Site Reaction 3.8%
Nausea 3.8%
Pyrexia 3.8%
Rash Vesicular 3.8%
Rheumatoid Arthritis 3.8%
Throat Irritation 3.8%
Thrombotic Thrombocytopenic Purpura 3.8%
Urinary Tract Infection 3.8%
White Blood Cell Count Increased 3.8%
Wound Abscess 3.8%
Wrong Technique In Drug Usage Process 3.8%

Drug Data